Los Angeles, CA49 Active Studies

Spinal Muscular Atrophy Clinical Trials in Los Angeles, CA

Find 49 actively recruiting spinal muscular atrophy clinical trials in Los Angeles, CA. Connect with local research sites and explore new treatment options.

49
Active Trials
34
Sponsors
35,639
Enrolling

Recruiting Spinal Muscular Atrophy Studies in Los Angeles

About Spinal Muscular Atrophy Clinical Trials in Los Angeles

Spinal muscular atrophy (SMA) is a genetic neuromuscular disorder that causes loss of motor neurons, leading to progressive muscle weakness and atrophy. It is the leading genetic cause of infant death. Revolutionary gene therapies and SMN-enhancing drugs have transformed treatment.

There are currently 49 spinal muscular atrophy clinical trials recruiting participants in Los Angeles, CA. These studies are seeking a combined 35,639 participants. Research is being sponsored by Heart Rhythm Clinical and Research Solutions, LLC, Tempus AI, Seagen, a wholly owned subsidiary of Pfizer and 31 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Spinal Muscular Atrophy Clinical Trials in Los Angeles — FAQ

Are there spinal muscular atrophy clinical trials in Los Angeles?

Yes, there are 49 spinal muscular atrophy clinical trials currently recruiting in Los Angeles, CA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Los Angeles?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Los Angeles research site will contact you about next steps.

Are clinical trials in Los Angeles free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Los Angeles studies also compensate for your time and travel.

What spinal muscular atrophy treatments are being tested?

The 49 active trials in Los Angeles are testing new therapies including novel drugs, biologics, and treatment approaches for spinal muscular atrophy.

Data updated August 28, 2026 from ClinicalTrials.gov